To review evidence supporting ALS as a neuromuscular disease, or as a neurodegenerative disease with neuromuscular manifestation
To discuss what, if any, clinical implications exist if the disease process is initiated centrally or peripherally
Professor of Neurology, Neuromuscular Diseases Unit/ ALS Clinic, Kantonsspital St.Gallen, Switzerland
Professor of Neurology emeritus, Barts and the London School of Medicine, QMUL, London UK
Professor of Neurology, Institute of Neuroscience (translational Neurophysiology), University of Lisbon, Lisbon Portugal
Professor of Neurology, Western University, London, Ontario, Canada
1:30 PM – 1:32 PM
1:32 PM – 1:37 PM
1:37 PM – 1:52 PM
1:52 PM – 2:07 PM
2:07 PM – 2:17 PM
Rebuttal: Neuromuscular vs. Neurodegenerative
Michael Swash, MD, FRCP, FRCPATH
Michael Strong, MD, FRCP(C), FANN, FCAHS
PLAY VIDEO2:17 PM – 2:27 PM
2:27 PM – 2:30 PM